Published on 24/12/2025
Implementing Remote Tools for Virtual Feasibility Evaluations in Clinical Trials
As clinical trials become increasingly global and decentralized, the feasibility evaluation process must also evolve. Traditional on-site visits and in-person feasibility assessments are no longer the only options. Remote tools for virtual feasibility evaluations offer an efficient, scalable alternative for selecting and qualifying investigational sites. This guide explores the essential technologies, benefits, and strategies for executing successful virtual feasibility assessments.
Why Virtual Feasibility Is Gaining Momentum
Virtual feasibility evaluations were initially accelerated by the COVID-19 pandemic, but their benefits have extended far beyond travel restrictions. Sponsors and CROs are increasingly relying on remote solutions to:
- Reduce travel time and cost
- Evaluate more sites in less time
- Ensure timely start-up in global trials
- Digitally document feasibility outcomes for audits
Organizations like StabilityStudies.in emphasize the value of digitized workflows and documentation across the trial lifecycle.
Core Tools for Virtual Feasibility Assessments
1. Electronic Feasibility Questionnaires
- Hosted via platforms like REDCap, Google Forms, or Typeform
- Customizable fields based on protocol-specific requirements
- Multilingual support for global outreach
2. Video Conferencing Platforms
- Zoom, Microsoft Teams, and Webex for real-time PI interviews
- Virtual site tours and discussions with study staff
- Screen sharing to review SOPs, logs, and site infrastructure
3. Clinical Trial Management Systems (CTMS)
- Centralized tracking of feasibility responses and timelines
- Integration with EDC
4. eSignature and Document Sharing Tools
- DocuSign, Adobe Sign for remote document execution
- SharePoint or OneDrive for uploading SOPs, CVs, and licenses
- Ensure compliance with data protection regulations like GDPR and HIPAA
5. Digital Scorecards and Feasibility Algorithms
- Automated scoring of site readiness based on weighted KPIs
- Excel templates, Power BI dashboards, or CTMS-integrated scoring
- Standardized metrics for objective site ranking
Steps for Conducting a Virtual Feasibility Evaluation
- Prepare a digital feasibility packet including the protocol synopsis, timeline, and expectations.
- Send electronic questionnaires to shortlisted sites with a defined deadline.
- Schedule virtual meetings with Principal Investigator and site staff for interviews.
- Request virtual tours of the pharmacy, lab, IP storage, and patient care areas.
- Use a standardized checklist to evaluate and score each site.
- Document and store all outcomes in the sponsor’s CTMS or eTMF.
Benefits of Remote Feasibility Tools
- Scalable site evaluations across multiple countries
- Faster turnaround for start-up decisions
- Reduced overheads for sponsors and CROs
- Minimized carbon footprint through reduced travel
Challenges and Mitigation Strategies
- Limited site technology access: Provide tech support or conduct hybrid assessments.
- Low response rates to digital forms: Use reminders and CRA engagement to boost compliance.
- Data integrity concerns: Store documents in validated CTMS platforms aligned with GMP compliance.
Compliance and Documentation Considerations
According to USFDA and EMA guidelines, feasibility activities—whether virtual or physical—must be documented and retained in the Trial Master File. Electronic feasibility documents must be time-stamped, version-controlled, and audit-ready.
Example: Hybrid Feasibility Approach
Many global sponsors now use hybrid models, where initial assessments are virtual, followed by on-site validation for selected sites. This balances speed and regulatory expectations.
Future of Virtual Feasibility
The future of feasibility is firmly digital. As decentralized trials grow, tools like AI-driven site selection, predictive feasibility scoring, and automated CRA dashboards will further streamline the process. Platforms like Pharma SOP documentation will continue to support digital readiness for all stakeholders involved in trial start-up.
Conclusion
Remote tools are transforming the feasibility landscape in clinical trials. By adopting a structured virtual feasibility strategy using modern tools, sponsors and CROs can reduce delays, improve data quality, and ensure global site readiness. Digital feasibility evaluations are no longer a convenience—they are a competitive advantage in modern clinical research.